Profile | GDS4284 / 210465_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1485.19 | 80 |
GSM687648 | Patient 402 control | 1254.01 | 77 |
GSM687653 | Patient 403 control | 1170.93 | 77 |
GSM687658 | Patient 404 control | 1367.39 | 79 |
GSM687663 | Patient 411 control | 1336.19 | 78 |
GSM687668 | Patient 422 control | 1564.66 | 80 |
GSM687673 | Patient 424 control | 1712.98 | 82 |
GSM687678 | Patient 425 control | 1342.73 | 78 |
GSM687683 | Patient 427 control | 1920.17 | 83 |
GSM687688 | Patient 428 control | 996.871 | 74 |
GSM687695 | Patient 441 control | 1052.79 | 76 |
GSM687699 | Patient 443 control | 1890.8 | 83 |
GSM687704 | Patient 444 control | 817.951 | 71 |
GSM687707 | Patient 448 control | 2774.45 | 88 |
GSM687712 | Patient 449 control | 1781.47 | 82 |
GSM687719 | Patient 450 control | 1266.49 | 77 |
GSM687724 | Patient 451 control | 1278.55 | 78 |
GSM687728 | Patient 452 control | 1355.15 | 79 |
GSM687646 | Patient 401 treated 24h | 1569.62 | 80 |
GSM687649 | Patient 402 treated 24h | 1221.82 | 77 |
GSM687665 | Patient 411 treated 24h | 1001.06 | 74 |
GSM687651 | Patient 402 treated 4 weeks | 1209.44 | 76 |
GSM687667 | Patient 411 treated 4 weeks | 1157.38 | 76 |
GSM687670 | Patient 422 treated 24h | 1926.91 | 83 |
GSM687671 | Patient 422 treated 4 weeks | 2116.98 | 84 |
GSM687654 | Patient 403 treated 24h | 1057.33 | 75 |
GSM687675 | Patient 424 treated 24h | 1891.65 | 83 |
GSM687685 | Patient 427 treated 24h | 1224.1 | 77 |
GSM687656 | Patient 403 treated 4 weeks | 1453.84 | 79 |
GSM687677 | Patient 424 treated 4 weeks | 1262.26 | 77 |
GSM687687 | Patient 427 treated 4 weeks | 2075.72 | 84 |
GSM687692 | Patient 428 treated 4h | 1630.25 | 81 |
GSM687716 | Patient 449 treated 4h | 1432.91 | 79 |
GSM687722 | Patient 450 treated 4h | 619.861 | 66 |
GSM687680 | Patient 425 treated 24h | 1080.36 | 75 |
GSM687690 | Patient 428 treated 24h | 1291.45 | 78 |
GSM687700 | Patient 443 treated 24h | 1138.22 | 76 |
GSM687705 | Patient 444 treated 24h | 428.091 | 62 |
GSM687714 | Patient 449 treated 24h | 1760.7 | 82 |
GSM687721 | Patient 450 treated 24h | 1168.12 | 77 |
GSM687682 | Patient 425 treated 4 weeks | 786.892 | 71 |
GSM687694 | Patient 428 treated 4 weeks | 1513.21 | 80 |
GSM687702 | Patient 443 treated 4 weeks | 1474.14 | 80 |
GSM687718 | Patient 449 treated 4 weeks | 1275.66 | 78 |
GSM687723 | Patient 450 treated 4 weeks | 1085.84 | 75 |
GSM687661 | Patient 404 treated 4h | 1564.48 | 80 |
GSM687710 | Patient 448 treated 4h | 2468.11 | 87 |
GSM687726 | Patient 451 treated 4h | 1557.25 | 81 |
GSM687730 | Patient 452 treated 4h | 74.7813 | 18 |
GSM687660 | Patient 404 treated 24h | 861.213 | 74 |
GSM687697 | Patient 441 treated 24h | 842.158 | 72 |
GSM687709 | Patient 448 treated 24h | 2437.42 | 87 |
GSM687725 | Patient 451 treated 24h | 1150.01 | 76 |
GSM687729 | Patient 452 treated 24h | 968.985 | 75 |
GSM687727 | Patient 451 treated 4 weeks | 958.653 | 73 |
GSM687731 | Patient 452 treated 4 weeks | 1403.1 | 79 |